NCT01164462

Brief Summary

Objective: This research agreement brings together French and Canadian teams of scientists, HIV testing centers and community based partners. The aim is to explore the feasibility and limitations of offering community based rapid HIV testing to men who have sex with men (MSM).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
357

participants targeted

Target at P50-P75 for not_applicable hiv-infections

Timeline
Completed

Started Mar 2010

Shorter than P25 for not_applicable hiv-infections

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 15, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 16, 2010

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

1.1 years

First QC Date

July 15, 2010

Last Update Submit

April 8, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • the feasibility of community-based rapid HIV testing. testing with community-based rapid testing

Secondary Outcomes (1)

  • Moreover it could compare traditional CDAG (Free Anonymous Screening Consultation) center

Study Arms (3)

A 2

OTHER

During the normal opening hours of five testing centers, clients with a rapid finger-stick blood specimen test

Biological: blood test: rapid finger-stick blood specimen testBiological: blood test: conventional test

B group

OTHER

During evenings and week-ends (i.e. when the centers are closed) only community based with rapid HIV testing

Biological: blood test: rapid finger-stick blood specimen testBiological: blood test: conventional test

A1 group

OTHER

During the normal opening hours of five testing centers, clients with a conventional test.

Biological: blood test: conventional test

Interventions

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • men who have sex with men
  • Age ≥ 18 years
  • Able to give written consent
  • able to give written authorization for lifting anonymity if there is doubt of results
  • Covered by French Social Security

You may not qualify if:

  • who have had a previous diagnosis of seropositivity
  • treated by antiretroviral
  • woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

CDAG (Free Anonymous Screening Consultation) center

Marseille, France

Location

CDAG (Free Anonymous Screening Consultation) center

Nice, France

Location

CDAG (Free Anonymous Screening Consultation) center

Paris, France

Location

Related Publications (1)

  • Lorente N, Preau M, Vernay-Vaisse C, Mora M, Blanche J, Otis J, Passeron A, Le Gall JM, Dhotte P, Carrieri MP, Suzan-Monti M, Spire B; ANRS-DRAG Study Group. Expanding access to non-medicalized community-based rapid testing to men who have sex with men: an urgent HIV prevention intervention (the ANRS-DRAG study). PLoS One. 2013 Apr 16;8(4):e61225. doi: 10.1371/journal.pone.0061225. Print 2013.

Related Links

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Vernay Vaisse Chantal

    DGAS DPMIS Marseille

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 15, 2010

First Posted

July 16, 2010

Study Start

March 1, 2010

Primary Completion

April 1, 2011

Study Completion

April 1, 2011

Last Updated

April 13, 2026

Record last verified: 2026-04

Locations